Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,175 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 103.07%. Jan-26 10 calls and Jul-25 5.5 calls are the most active options, with total volume in those strikes near 2,300 contracts. The Put/Call Ratio is 0.24. Earnings are expected on August 7th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
- Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals